Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B-Reference-Cited by-同舟云学术

Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B

Published:2018-05-06 Issue:2 Volume:68 Page:425-434
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Jeng Wen-Juei¹²,Chen Yi-Cheng¹²,Chien Rong-Nan¹²,Sheen I-Shyan¹²,Liaw Yun-Fan¹^ORCID

Affiliation:

1. Liver Research Unit, Chang Gung Memorial Hospital; Chang Gung University College of Medicine; Taipei Taiwan

2. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital; Linkou Medical Center; Taoyuan City Taiwan

Funder

Chang Gung Medical Research Fund

National Science Council

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29640/fullpdf

Reference27 articles.

1. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

2. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2017

3. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol Int,2012

4. Pharmacotherapeutic options for hepatitis B;Chen;Expert Opin Pharmacother,2016

5. Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs);Grossi;Liver Int,2017

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review;Journal of Viral Hepatitis;2024-08-16

2. ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B;Journal of Hepatology;2024-08

3. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment;Journal of Microbiology, Immunology and Infection;2024-08

4. Unmet needs in the clinical management of chronic hepatitis B infection;Journal of the Formosan Medical Association;2024-08

5. Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study);Journal of Hepatology;2024-08